Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Gel formulation of IQP-0528 plus tenofovir evaluated in vitro as HIV therapy

Dec. 28, 2010

New CREB-1 inhibitor XX-650-23 shows promise to treat AML

Dec. 28, 2010

In vitro data support potential benefits of TT-30 in complement-mediated diseases

Dec. 28, 2010

Asymmetrical CADA analogue VGD-020 displays improved potency against CD4

Dec. 28, 2010

HDAC inhibitor PCI-24781 displays in vivo anti-inflammatory effects

Dec. 27, 2010

Cyclacel's cell cycle inhibitor CYC-065 suppresses growth of MM cell in vitro

Dec. 27, 2010

Chimerix's CMX-157 is safe in first-in-human study in healthy volunteers

Dec. 27, 2010

Combination of AZD-0530 and anastrozole shows promise in hormone receptor-positive breast cancer

Dec. 24, 2010

Lower risk of metabolic complications seen with darunavir vs. atazanavir plus ritonavir in HIV

Dec. 24, 2010

Lentiviral vector-based vaccine VRX-1116 shows promise in HIV therapy

Dec. 24, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...